220 related articles for article (PubMed ID: 26654843)
1. Antiviral agents against equid alphaherpesviruses: Current status and perspectives.
Vissani MA; Thiry E; Dal Pozzo F; Barrandeguy M
Vet J; 2016 Jan; 207():38-44. PubMed ID: 26654843
[TBL] [Abstract][Full Text] [Related]
2. Antiherpetic Drugs in Equine Medicine.
Maxwell LK
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):99-125. PubMed ID: 28325183
[TBL] [Abstract][Full Text] [Related]
3. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
Dunowska M
N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of acyclovir, ganciclovir and cidofovir against equid alphaherpesvirus 3 and evaluation of their efficacy against six field isolates.
Vissani MA; Zabal O; Tordoya MS; Parreño V; Thiry E; Barrandeguy M
Rev Argent Microbiol; 2018; 50(4):380-390. PubMed ID: 29779880
[TBL] [Abstract][Full Text] [Related]
5. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
Dunowska M
N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
[TBL] [Abstract][Full Text] [Related]
6. Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in combination.
Thieulent C; Hue ES; Sutton G; Fortier C; Dallemagne P; Zientara S; Munier-Lehmann H; Hans A; Paillot R; Vidalain PO; Pronost S
Antiviral Res; 2020 Nov; 183():104931. PubMed ID: 32926887
[TBL] [Abstract][Full Text] [Related]
7. Equine herpes myeloencephalopathy in a 12-year-old American quarter horse.
Wong D; Scarratt WK
Vet Clin North Am Equine Pract; 2006 Apr; 22(1):177-91. PubMed ID: 16627115
[No Abstract] [Full Text] [Related]
8. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants.
Glorieux S; Vandekerckhove AP; Goris N; Yang XY; Steukers L; Van de Walle GR; Croubels S; Neyts J; Nauwynck HJ
Antiviral Res; 2012 Feb; 93(2):234-238. PubMed ID: 22178244
[TBL] [Abstract][Full Text] [Related]
10. Key Determinants in the Pathogenesis of Equine Herpesvirus 1 and 4 Infections.
Hussey GS
Vet Pathol; 2019 Sep; 56(5):656-659. PubMed ID: 31394999
[No Abstract] [Full Text] [Related]
11. An Alphaherpesvirus Exploits Antimicrobial β-Defensins To Initiate Respiratory Tract Infection.
Van Cleemput J; Poelaert KCK; Laval K; Vanderheijden N; Dhaenens M; Daled S; Boyen F; Pasmans F; Nauwynck HJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996426
[TBL] [Abstract][Full Text] [Related]
12. Equine herpesvirus-1: a neurotropic alphaherpesvirus.
Slater JD; Borchers K; Field HJ
Vet Rec; 1994 Sep; 135(10):239-40. PubMed ID: 7801451
[No Abstract] [Full Text] [Related]
13. Herpesvirus latency and therapy--from a veterinary perspective.
Field HJ; Biswas S; Mohammad IT
Antiviral Res; 2006 Sep; 71(2-3):127-33. PubMed ID: 16843537
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus-1 consensus statement.
Lunn DP; Davis-Poynter N; Flaminio MJ; Horohov DW; Osterrieder K; Pusterla N; Townsend HG
J Vet Intern Med; 2009; 23(3):450-61. PubMed ID: 19645832
[TBL] [Abstract][Full Text] [Related]
15. Equine herpesvirus myeloencephalopathy: unravelling the enigma.
Nugent J; Paillot R
Vet J; 2009 Jun; 180(3):271-2. PubMed ID: 19141371
[No Abstract] [Full Text] [Related]
16. Screening and evaluation of antiviral compounds against Equid alpha-herpesviruses using an impedance-based cellular assay.
Thieulent CJ; Hue ES; Fortier CI; Dallemagne P; Zientara S; Munier-Lehmann H; Hans A; Fortier GD; Pitel PH; Vidalain PO; Pronost SL
Virology; 2019 Jan; 526():105-116. PubMed ID: 30388626
[TBL] [Abstract][Full Text] [Related]
17. A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response.
Normand C; Thieulent CJ; Fortier C; Sutton G; Senamaud-Beaufort C; Jourdren L; Blugeon C; Vidalain PO; Pronost S; Hue ES
Viruses; 2024 May; 16(5):. PubMed ID: 38793627
[TBL] [Abstract][Full Text] [Related]
18. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
Frampton AR; Goins WF; Cohen JB; von Einem J; Osterrieder N; O'Callaghan DJ; Glorioso JC
J Virol; 2005 Mar; 79(5):3169-73. PubMed ID: 15709036
[TBL] [Abstract][Full Text] [Related]
19. Equine herpesviruses 1 and 4: creeping to a solution.
Smith K
Vet J; 2005 Jul; 170(1):6-7. PubMed ID: 15914048
[No Abstract] [Full Text] [Related]
20. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
Kydd JH; Townsend HG; Hannant D
Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
